Install
Eli Lilly
Eli Lilly: hiring, expansion, leadership and results.
- 2 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Eli Lilly
This Drug Combination for Eli Lilly Generated Significantly More Weight Loss Than Just Zepbound, but Discontinuation Rates Were Also Far Higher. Here's What This Could Mean for the Stock
2+ hour, 6+ min ago (383+ words) The Motley Fool Although Eli Lilly (LLY +0.41%) is a leader in the GLP-1 space, the drugmaker continues to develop new and potentially better treatments for people to lose weight. Not everyone has success with GLP-1 drugs or can effectively tolerate…...
Ground broken on $6.5bn Eli Lilly manufacturing facility for GLP-1
4+ day, 4+ hour ago (147+ words) Construction at Generation Park will employ 4,000 workers, while 600 jobs will be created at the plant once operational. Eli Lilly is spending $12.5m to support San Jacinto College students into advanced chemical synthesis manufacturing careers and is also funding equipment. Foundayo, is…...
900 Eli Lilly and Company $LLY Shares Sold by Castle Rock Wealth Management LLC
2+ day, 7+ hour ago (137+ words) Posted by Defense World Staff on Oct 10th, 2026 View Our Latest Stock Report on Eli Lilly and Company Eli Lilly and Company is a global pharmaceutical company headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company researches, develops,…...
Eli Lilly-backed TRex Bio closes day flat after IPO
2+ day, 17+ hour ago (82+ words) TradingView Eli Lilly-backed TRex Bio closes day flat after IPO - TRex Bio, which is backed by Eli Lilly, closed Friday, its first day of trading, at its IPO price, $14. - Shares opened at $13.50. They traded mostly below $14 throughout the day, although…...
Eli Lilly’s Biggest Shareholder Just Filed to Sell $347 Million of Stock
2+ day, 21+ hour ago (1071+ words) Lilly's largest shareholder just filed to unload nearly $350 million in stock while analysts keep raising their price targets, and those two facts point in opposite directions for investors trying to read the room. Eli Lilly (NYSE:LLY | LLY Price Prediction)…...
Eli Lilly: Endowment proposes $347M share sale
4+ day, 19+ hour ago (250+ words) The proposed 300,000-share sale would go through J.P. Morgan Securities LLC, with an approximate sale date of October 7, 2026, according to the notice. Eli Lilly: Endowment proposes $347M share sale Lilly Endowment, Inc. also reported four common-stock sales during the preceding three months,…...
Zealand Pharma (CPSE:ZEAL) Reports Positive Phase 2 Petrelintide Results In Type 2 Diabetes
3+ day, 5+ hour ago (417+ words) Zealand Pharma (CPSE:ZEAL) reported positive topline Phase 2 ZUPREME-2 data for its amylin analog petrelintide in adults with overweight or obesity and type 2 diabetes. The company said petrelintide delivered clinically meaningful weight reduction and HbA1c improvement in the ZUPREME-2 study population....
Zealand Pharma reports up to 9.2% weight loss in Phase 2 diabetes trial
4+ day, 8+ hour ago (786+ words) The 220-person ZUPREME-2 trial also showed improved HbA1c; Zealand says the first participants have begun treatment in its Phase 3a program. Weight loss of up to 9.2 per cent in a diabetes trial adds evidence for petrelintide's obesity program after Zealand Pharma A…...
Global DPP-4 inhibitors market to grow to $15.5B by 2032, driven by type 2 diabetes demand and generics expansion.
3+ day, 20+ hour ago (283+ words) The global market for Dipeptidyl Peptidase-4 (DPP-4) inhibitors, used in type 2 diabetes treatment, is projected to grow from $11.28 billion in 2025 to $15.53 billion by 2032, at a CAGR of 5.47%. Growth is fueled by the ongoing global burden of type 2 diabetes, demand for…...
Eli Lilly and Company: News in other languages | LLY | US5324571083
4+ day, 19+ hour ago (40+ words) Eli Lilly and Company: News, information and stories for Eli Lilly and Company | NYSE: LLY | NYSE Berenberg Upgrades Eli Lilly to Buy September 15, 2026 at 02:31 pm EDT Lilly to Buy Merida for $2.88 Billion in Autoimmune Push...